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Aim: To characterize sequence variations in the ANK gene in fam- 
ilies with autosomal dominant CPPDD. 
Methods and Results: Analyses included screening for 
sequence variants in all 12 exons, including intron/exon splice 
junctions, as well as analysis of 200 bp of the 5'UTR region. Also, 
Southern blot analyses were performed to detect major deletions, 
re-arrangements, or insertions of the gene, and quantitative RT- 
PCR was utilized to determine relative levels of expression of 
AINK transcripts in fibrobiasts from affected family members ver- 
sus controls. Numerous sequence variants were detected in ANK; 
these included exon and intron SNPs, as well as a SNP in the 5' 
UTR region of the gene. In one family, a heterozygous base sub- 
stitution in exon 1 changed a proline to threonine at position 5; 
however, this variant did not occur on the disease haplotype, 
suggesting that it is a polymorphism that is not associated with 
the disease in this family. There was no evidence of a major gene 
defect, and analysis of expression levels for ANK in our families 
was unremarkable. 
Conclusions: Familial CPPDD is a genetic disorder of articular 
cartilage that is characterized by the deposition of calcium-con- 
taining crystals in affected joints. Genetic analyses of numerous 
families whose CPPDD segregates as a dominant rait have iden- 
tiffed a locus (CCAL2) on the short arm of chromosome 5 that 
harbors a gone that is responsible for the disease. There are sev- 
eral positional candidates in the CPPDD chromosome 5p interval, 
including ANK, the human homolog of the mouse progressive 
ankylosis (ank) gene. ANK codes for an integral membrane pro- 
tein that acts as a transmembrane transporter for inorganic 
pyrophosphate (PPi). In recessive ank/ank mice, loss of ank activ- 
ity apparently leads to a drop in extracellutar PPi levels, resulting 
in unregulated apatite calcification in joints. In light of the numer- 
ous reports of anomalous regulation of PPi metabolism in 
patients with CPPDD, we undertook characterization of ANK in 
our 5p CPPDD families. Our observations uggest that ANK is not 
the gene responsible for CPPDD in these families. However, 
information with regard to polymorphisms inthis gene will be use- 
ful in future studies of genetic association and linkage disequilib- 
rium. 
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Aim: To assess whether overexpression of Smad-6 and -7 
blocks TGF-13 activity in cultured chondrocytes. 
Methods: Bioactivity of Smad-6 and -7 was determined via the 
ability to block TGF-[] responses on a TGF-~ sensitive cell line 
(MLEC). Chondrocytes were transfected with adenoviruses con- 
taining the gene encoding Smad-6, -7 or luciferase or were not 
transfected. Transfected cells were stimulated for 48 hours with 
TGF-I~ and compared to unstimulated cells. The effect of Ad- 
Smad-6 and -7 on chondrocyte proliferation (DNA content) and 
PG synthesis (35S incorporation) was studied. Protein expression 
of Smad-7 was performed via immunocytochemistry using an 
anti-Smad-7Ab. Expression levels of Smad-6, -7 and aggrecan 
were examined by semi-quantitative RT-PCR. 
Results: Ad-Smad-7 was able to inhibit 95.5% of TGF-~ 
induced luminescence in the MLEC cells, whereas Ad-Smad-6 
only inhibited TGF-I~ responses for 25%. Transfection of chon- 
drocytes with Ad-Smad-6 or -7 upregulated mRNA for Smad-6 
110 times and Smad-7 357 times, respectively, compared with 
Ad-luciferase. On the protein level, Smad-7 was readily detected 
in chondrocytes transfected with Ad-Smad-7 and not in any of 
the control treated cells. Smad-6 protein expression could not be 
determined because of nonspecificity of the antibody. As expect- 
ed, TGF-~ induced an increase in chondrocyte cell number, which 
could be completely inhibited by Ad-Smad-7 only. Moreover, the 
increase in PG synthesis induced by TGF-~ (corrected for cell 
number) could be blocked for 90% by Ad-Smad-7 and for 47% 
by Ad-Smad-6 and not by Ad-luciferase. The TGF-~ induced 
upregulation of aggrecan on the mRNA level could be complete- 
ly blocked with Ad-Smad-7 but not with Ad-Smad-6 or Ad- 
luciferase. 
Conclusions: The TGF-13 family uses receptor-associated 
Smads and the common mediator Smad-4 to transduce its signal 
to the nucleus. Smads-6 and -7 are strongly implied in the inhibi- 
tion of the TGF-I3 family signaling pathway. We tested the feasi- 
bility of Smad-6 and -7 as possible TGF-~ inhibitors in chondro- 
cytes. Smad-6 incompletely blocked TGF-I~ effects on MEEC 
cells and on PG synthesis and is therefore only a partial inhibitor 
for TGF-~ in chondmcytes. In contrast, Smad-7 could fully inhib- 
it all TGF-~ induced responses in chondrocytes we investigated. 
We conclude that Smad-7 is a very potent TGF-~ antagonist and 
that Ad-Smad-7 is a powerful tool to study TGF-~ effects in vivo. 
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To identify patterns of gene expression products that are specifi- 
cally regulated in osteoarthritis (OA) compared with rheumatoid 
arthritis (RA) and the healthy state (ND), gene expression was 
monitored by subtractive hybridization with representational dif- 
ference analysis (RDA), and by complex hybridizations on cDNA 
chips. RDA was performed by subtracting OA from RA represen- 
tations and ND from OA representations. The difference-products 
were selectively amplified, cloned, sequenced and compared to 
published sequences in the Genebank. - Microarray hybridiza- 
tions were carried out using arrayed cDNA tags (Affymetrix) of 
approx. 60,000 genes. Differential expression of identified genes 
was validated by semiquantitative RT-PCR. Approximately 100 
genes were found to be differentially expressed in OA synovial 
tissue compared to ND tissues. Genes of highest regulation were 
associated with leukocyte activation (3" cells antigens, sema- 
phorine, cell surface proteins), with tissue destruction and remod- 
eling (MMP-1, BMP-3b), and extracellular matrix components 
(integrins, fibronectin). Interestingly, a large set of genes was 
found downregulated in BA and OA, such as members of the 
TGF-b superfamily, apoptosls associated molecules or transcrip- 
tion factors. Beside genes already described as relevant in the 
pathogenesis of OA, others have not been assigned to this back- 
